Ulcerative colitis after statin treatment

Postgraduate Medical Journal

Volumn 78, Issue 919, 2002, Pages 286-287

  Rea, W E ^a   Durrant, D C S ^a   Boldy, David A R ^a  

^a PILGRIM HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ENALAPRIL; PRAVASTATIN; SIMVASTATIN; STATINE; HYPOCHOLESTEROLEMIC AGENT;

ABDOMINAL PAIN; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE COURSE; DRUG WITHDRAWAL; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MALE; TREATMENT OUTCOME; ULCERATIVE COLITIS; CHEMICALLY INDUCED DISORDER;

AGED; ANTICHOLESTEREMIC AGENTS; COLITIS, ULCERATIVE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; SIMVASTATIN;

EID: 0036261220     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.919.286     Document Type: Article

References (10)

1. Joint British recommendations on prevention of coronary heart disease in clinical practice
2. Statine [The statins]
3. Simvastatin-induced protein-losing enteropathy
4. Role of nitric oxide in the colon of patients with ulcerative colitis
5. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
6. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects - The relevance of endothelial nitric oxide synthase and superoxide anion scavenging action
7. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors
8. Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis
9. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats